Anton Legin

Dr. Anton Legin


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2014 in Chemical Science
Verified
Journal Article
Open access
PDF file
ALAnton Legin
Anton Legin
ASArno Schintlmeister
Arno Schintlmeister
MJMichael A. Jakupec
Michael A. Jakupec
Mathea Sophia GalanskiMathea Sophia Galanski
Mathea Sophia Galanski
ILIrene Lichtscheidl
Irene Lichtscheidl
BKBernhard K. Keppler
Bernhard K. Keppler
NanoSIMS combined with fluorescence microscopy reveals subcellular structures in cancer cells where 15N-labeled cisplatin is accumulated, with implications for Pt–N bond integrity.

25 December 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
BNBenjamin Neuditschko
Benjamin Neuditschko
ALAnton Legin
Anton Legin
DBDina Baier
Dina Baier
ASArno Schintlmeister
Arno Schintlmeister
SRSiegfried Reipert
Siegfried Reipert
Christopher GernerChristopher Gerner
Christopher Gerner
The ruthenium‐based anticancer agent BOLD‐100/KP1339 has shown promising results in several in vitro and in vivo tumour models as well as in early clinical trials. However, its mode of action remains to be fully elucidated. Recent evidence identified stress induction in the endoplasmic reticulum (ER) and concomitant down‐modulation of HSPA5 (GRP78) as key drug effects. By exploiting the naturally formed adduct between BOLD‐100 and human serum albumin as an immobilization strategy, we were able to perform target‐profiling experiments that revealed the ribosomal proteins RPL10, RPL24, and the transcription factor GTF2I as potential interactors of this ruthenium(III) anticancer agent. Integrating these findings with proteomic profiling and transcriptomic experiments supported ribosomal disturbance and concomitant induction of ER stress. The formation of polyribosomes and ER swelling of treated cancer cells revealed by TEM validated this finding. Thus, the direct interaction of BOLD‐100 with ribosomal proteins seems to accompany ER stress‐induction and modulation of GRP78 in cancer cells.

17 April 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
SIStefanie Imminger
Stefanie Imminger
DMDimitri V. Meier
Dimitri V. Meier
ASArno Schintlmeister
Arno Schintlmeister
ALAnton Legin
Anton Legin
JSJörg Schnecker
Jörg Schnecker
DWDagmar Woebken
Dagmar Woebken
Microbial activity in drylands tends to be confined to rare and short periods of rain. Rapid growth should be key to the maintenance of ecosystem processes in such narrow activity windows, if desiccation and rehydration cause widespread cell death due to osmotic stress. Here, simulating rain with 2H2O followed by single-cell NanoSIMS, we show that biocrust microbial communities in the Negev Desert are characterized by limited productivity, with median replication times of 6 to 19 days and restricted number of days allowing growth. Genome-resolved metatranscriptomics reveals that nearly all microbial populations resuscitate within minutes after simulated rain, independent of taxonomy, and invest their activity into repair and energy generation. Together, our data reveal a community that makes optimal use of short activity phases by fast and universal resuscitation enabling the maintenance of key ecosystem functions. We conclude that desert biocrust communities are highly adapted to surviving rapid changes in soil moisture and solute concentrations, resulting in high persistence that balances limited productivity.

26 August 2021 in Chemical Science
Verified
Journal Article
Open access
PDF file
HSHemma Schueffl
Hemma Schueffl
STSarah Theiner
Sarah Theiner
GHGerrit Hermann
Gerrit Hermann
JMJosef Mayr
Josef Mayr
PFPhilipp Fronik
Philipp Fronik
PHPetra Heffeter
Petra Heffeter
Albumin-targeting of a maleimide-containing oxaliplatin-releasing platinum(iv) prodrug results in tumor-specific drug delivery and activity as shown by LA-ICP-MS, isotope-labeling and NanoSIMS in cell culture and in vivo.

14 August 2024 in Nature
Verified
Journal Article
Open access
PDF file
MPMarton Palatinszky
Marton Palatinszky
CHCraig Herbold
Craig Herbold
CSChristopher J. Sedlacek
Christopher J. Sedlacek
DPDominic Pühringer
Dominic Pühringer
KKKatharina Kitzinger
Katharina Kitzinger
MWMichael Wagner
Michael Wagner
Guanidine is a chemically stable nitrogen compound that is excreted in human urine and is widely used in manufacturing of plastics, as a flame retardant and as a component of propellants, and is well known as a protein denaturant in biochemistry1–3. Guanidine occurs widely in nature and is used by several microorganisms as a nitrogen source, but microorganisms growing on guanidine as the only substrate have not yet been identified. Here we show that the complete ammonia oxidizer (comammox) Nitrospira inopinata and probably most other comammox microorganisms can grow on guanidine as the sole source of energy, reductant and nitrogen. Proteomics, enzyme kinetics and the crystal structure of a N. inopinata guanidinase homologue demonstrated that it is a bona fide guanidinase. Incubation experiments with comammox-containing agricultural soil and wastewater treatment plant microbiomes suggested that guanidine serves as substrate for nitrification in the environment. The identification of guanidine as a growth substrate for comammox shows an unexpected niche of these globally important nitrifiers and offers opportunities for their isolation.

26 November 2020 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
ALAnton Legin
Anton Legin
ASArno Schintlmeister
Arno Schintlmeister
NSNadine S. Sommerfeld
Nadine S. Sommerfeld
MEMargret Eckhard
Margret Eckhard
STSarah Theiner
Sarah Theiner
BKBernhard K. Keppler
Bernhard K. Keppler
Oxaliplatin shows a superior clinical activity in colorectal cancer compared to cisplatin. Nevertheless, the knowledge about its cellular distribution and the mechanisms responsible for the different range of oxaliplatin-responsive tumors is far from complete. In this study, we combined highly sensitive element specific and isotope selective imaging by nanometer-scale secondary ion mass spectrometry (NanoSIMS) with transmission electron microscopy to investigate the subcellular accumulation of oxaliplatin in three human colon cancer cell lines (SW480, HCT116 wt, HCT116 OxR). Oxaliplatin bearing dual stable isotope labeled moieties, i.e.2H-labeled diaminocyclohexane (DACH) and 13C-labeled oxalate, were applied for comparative analysis of the subcellular distribution patterns of the central metal and the ligands. In all the investigated cell lines, oxaliplatin was found to have a pronounced tendency for cytoplasmic aggregation in single membrane bound organelles, presumably related to various stages of the endocytic pathway. Moreover, nuclear structures, heterochromatin and in particular nucleoli, were affected by platinum-drug exposure. In order to explore the consequences of oxaliplatin resistance, subcellular drug distribution patterns were investigated in a pair of isogenic malignant cell lines with distinct levels of drug sensitivity (HCT116 wt and HCT116 OxR, the latter with acquired resistance to oxaliplatin). The subcellular platinum distribution was found to be similar in both cell lines, with only slightly higher accumulation in the sensitive HCT116 wt cells which is inconsistent with the resistance factor of more than 20-fold. Instead, the isotopic analysis revealed a disproportionally high accumulation of the oxalate ligand in the resistant cell line.